Stock Events

Stock Events

Merrimack Pharmaceuticals (MACK) Q2 2023 Earnings

3AugConfirmed

Nov 22

Q4 2022

Q1 2023

Q2 2023

-0.03

-0.03

-0.02

-0.02

Details

Expected EPS

N/A

Actual EPS

-0.03

Surprise EPS

-0.03

Surprise Percent

+∞%

Description

Merrimack Pharmaceuticals (MACK) has reported earnings of -0.03 per share for Q2 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.